RNA in Therapeutics: CRISPR in the Clinic.
Mol Cells
; 46(1): 4-9, 2023 Jan 31.
Article
in En
| MEDLINE
| ID: mdl-36482771
The advent of the CRISPR-Cas genome editing platform has greatly enhanced the capabilities of researchers in many areas of biology. Its use has also been turned to the development of therapies for genetic diseases and to the enhancement of cell therapies. This review describes some recent advances in these areas.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
RNA
/
CRISPR-Cas Systems
Language:
En
Journal:
Mol Cells
Year:
2023
Document type:
Article